Tracker Ventures Corp. Announces Submission of 2A Listing Statement to the Canadian Securities Exchange and Restructuring of Contakt Transaction

Tracker Ventures Corp. (the "Company" or "Tracker") (CSE:TKR)(OTC PINK:TLOOF)(FWB:B2I) is pleased to announce, further to its news releases dated October 30, 2020, October 19, 2020, and October 6, 2020, the Company has submitted a Form 2A Listing Statement ("Listing Statement") to the Canadian Securities Exchange ("CSE") respecting the Company's pending acquisition (the "Acquisition") of Contakt World Technologies Corp. ("Contakt World

Trading of Tracker's shares on the CSE remains halted in connection with the pending Acquisition and are not expected to resume until the CSE has approved the above noted Listing Statement for the resulting issuer from the Acquisition.

Zayn Kalyan, Tracker's Chief Technology Officer and interim Chief Financial Officer, stated "We are very excited to announce the submission of the Listing Statement to the CSE. Our team has been working very hard towards completing the Acquisition of Contakt World Technologies Corp. ("Contakt World") and today marks another milestone in the process."

"The submission of the 2A Listing Statement is a testament to the mutual progress the Tracker and Contakt teams have made over the past two months. While trading of Tracker's shares remains halted for the time being, our team has been working hard to commercialize the Contakt World platform in the near term, which we expect could save countless lives as health agencies together with businesses and institutions in their jurisdictions deploy our solutions," stated Justin Beck, Chief Executive Officer and Founder of Contakt World.

The Company is also pleased to announce that it has restructured the Acquisition pursuant to an amalgamation agreement (the "Amalgamation Agreement") entered into with its wholly-owned subsidiary, 1276313 B.C. LTD. ("Subco"), and Contakt World, Contakt LLC and certain founding shareholders of Contakt LLC (the "Founding Shareholders"). The Amalgamation Agreement replaces and supersedes the share exchange agreement (the "Share Exchange Agreement") dated October 30, 2020 among the Company, Contakt World, Contakt LLC and the Founding Shareholders.

Pursuant to the Amalgamation Agreement, the Acquisition will be carried out by way of a three-cornered amalgamation, whereby Subco and Contakt World will amalgamate and Contakt World will become a wholly-owned subsidiary of the Company. The Amalgamation Agreement was structured to reflect the same deal terms as those set forth in the Share Exchange Agreement, including in respect of conditions to closing, consideration and composition of the resulting issuer board.

About Contakt World

Contakt World is a technology company innovating public health agency connections with their community, with the goal of becoming the most trustworthy, accessible and scalable digital public health and safety platform globally - addressing the needs of a post-pandemic world. Contakt World combines aggressive research and development, human-centered design, next-gen data integrations, and strategic health partnerships to empower and build mutual trust within communities, contributing towards health equity for users around the world. Contakt World's first suite of tools emerge from the urgency surrounding coronavirus to manage the pandemic through innovative contact tracing and case management spanning multiple modes of communication. For more information, please visit the Company's website at www.contakt.world.

About Tracker Ventures Corp.

Tracker Ventures (CSE:TKR; OTC:TLOOF; FWB: B2I) is an analytics software company that leverages blockchain and digital asset technology to transform and modernize multiple industries. Tracker is taking a diversified approach to the analytics and technology space, delivering practical solutions in the health, finance, logistics and pharmaceutical industries. The Company's turnkey real-time tracking solutions offer the very latest in IoT and AI, providing valuable data and business intelligence to some of the world's leading brands. For more information, please visit www.tkrventures.com.

Tracker Ventures Contact

Geoff Balderson
CEO and Director
Direct: 604-602-0001

Contakt Investor Contact

Lucas A. Zimmerman
Senior Vice President - MZ North America
Direct: 949-259-4987
contakt@mzgroup.us
www.mzgroup.us

Contakt Media Contact

Kevin Harrington
Account Director - 5WPR
contaktPR@5wpr.com

Forward Looking-Statements

Certain information set forth in this press release contains statements that reflect "forward-looking information", as such term is defined under Canadian securities laws ("forward-looking statements"). These forward-looking statements are often identified by words such as "intends", "anticipates", "expects", "believes", "plans", "likely" or similar words. Specifically, this news release includes forward looking statements regarding completion of the Acquisition and the timing thereof, the conditions precedent to completion of the Acquisition, the Company's future business plans once the Acquisition has been completed and the CSE's approval of the Listing Statement. The forward-looking statements reflect the Company's and Contakt World's respective management's expectations, estimates, or projections concerning future results or events, based on the opinions, assumptions and estimates considered reasonable by management at the date the statements are made. Although the Company and Contakt World believe that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements involve risks and uncertainties, and undue reliance should not be placed on forward-looking statements, as unknown or unpredictable factors could cause actual results to be materially different from those reflected in the forward-looking statements. Among the key factors that could cause actual results to differ materially are: whether the parties are able to satisfy the relevant conditions precedent under the Amalgamation Agreement; and whether the parties are able to obtain all necessary regulatory approvals for the Acquisition. The forward-looking statements may also be affected by risks and uncertainties in the business of Tracker, including those described in the Company's public filings available on www.SEDAR.com. The Company undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change, except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.

SOURCE: Tracker Ventures Corp.



View source version on accesswire.com:
https://www.accesswire.com/619923/Tracker-Ventures-Corp-Announces-Submission-of-2A-Listing-Statement-to-the-Canadian-Securities-Exchange-and-Restructuring-of-Contakt-Transaction

News Provided by ACCESSWIRE via QuoteMedia

The Conversation (0)
Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") announces results from its most recent preclinical study of its Targeted Hyperthermia Therapy ("THT") which uses the Company's patented, biocompatible gold nanorods ("GNRs") to treat certain solid cancer tumors, shrinking them and acting as an immune stimulator. Building on its success in melanoma and breast cancer studies, the Company's third preclinical efficacy study was conducted in an immunologically 'cold' colorectal cancer model ("CT26"), a model that represents the majority of human colon cancers, which do not typically respond to current standard of care immunotherapies.

In this preliminary study, whereas no mice that were given standard immunotherapy alone showed any response, 100% of mice in the THT treatment group responded to the same immunotherapy with 50% (4 out of 8) of those tumors eliminated within 12 days of treatment, as shown by the green line in Figure 1, below.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is pleased to announce the establishment of its new Advisory Board. The Advisory Board will collaborate with management and the board of directors to enhance the Company's strategic direction, provide expert guidance on its commercial initiatives, offer industry insights, and shape and accelerate innovations.

As the inaugural member of the Advisory Board, Syntheia welcomes Mr. John Kirk, a leader in the travel industry. The travel sector represents a potentially significant growth market for the Company's technology.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Syntheia Enhances Inbound Customer Calls with AI-Powered Virtual Assistants, Positively Impacts Sales and Customer Satisfaction

Syntheia Enhances Inbound Customer Calls with AI-Powered Virtual Assistants, Positively Impacts Sales and Customer Satisfaction

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is transforming customer service by delivering an innovative solution that uses natural language processing (NLP) to handle inbound telephone calls with virtual assistants. Since its beta launch in June 2023, Syntheia has processed over 750,000 conversations, bringing new levels of efficiency and engagement to businesses in diverse industries.

Companies like Georgetown Hyundai, Palmieri Furniture, Campio Furniture, and Pay N Go have all embraced Syntheia's platform, highlighting its positive impact on sales and customer satisfaction.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Zero Candida Technologies Inc.  Opens the Market

Zero Candida Technologies Inc. Opens the Market

Eli Ben-Haroosh, Co-Founder and Chief Executive Officer, Zero Candida Technologies Inc. (TSXV: ZCT) ("Zero Candida" or the "Company"), joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange, to open the market to celebrate the Company's new listing on the TSX Venture Exchange.

Zero Candida Technologies, Inc. (ZCT), is a medical device company bringing female healthcare into the 21st century. They are transforming the treatment of Vulvo-Vaginal Candidiasis ("VVC"), which affects 75% of women worldwide, often recurrent and increasingly drug-resistant with current treatments failing to address the root cause effectively. Free from chemicals and side effects, their AI-driven tampon-like device enables real-time data collection and transmission to physicians for personalized, at-home treatment. Beyond VVC, ZCT aims to revolutionize gynecology, improving access for underserved populations and advancing hybrid medicine.

Please refer to the Company's website here.

MEDIA CONTACT:
Victoria Gamble
Corporate Development Consultant
victoria@zero-candida.com
416-706-0332

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/231280

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
XReality Group

xReality Group Limited Chairman’s Address 2024 Annual General Meeting – 22 November 2024

xReality Group Limited (ASX:XRG) (xReality) is pleased to present xReality Group Limited’s 2024 Annual General Meeting.

Keep reading...Show less
XReality Group

Operator XR – Sales Update November 24

xReality Group Limited (ASX:XRG) (xReality) is pleased to provide the following sales update for Operator XR, a wholly owned subsidiary of xReality Group Ltd. Operator XR provides Military and Law Enforcement agencies around the world with a unique, integrated Mission Planning & Rehearsal System, which is portable, secure, and highly immersive.

Keep reading...Show less

Latest Press Releases

Related News

×